Cardiovascular Complications of HIV-Associated Immune Dysfunction

Area of Science:

• Infectious Diseases
• Cardiology
• Immunology

Background:

• Prolonged survival in HIV infection leads to increased non-HIV-related comorbidities.
• Cardiovascular diseases (CVD) occur earlier and at higher rates in HIV-positive individuals compared to HIV-negative individuals.

Purpose of the Study:

• To explore the contributing factors to increased cardiovascular disease risk in HIV-infected patients.
• To highlight the role of immune dysfunction and inflammation as nontraditional risk factors for CVD in HIV.

Main Methods:

• Review of proposed traditional and nontraditional risk factors for CVD in HIV.
• Examination of elevated inflammatory markers (e.g., hs-CRP, D-dimer, IL-6) and their association with CVD risk.

Main Results:

• Immune dysfunction is a significant nontraditional risk factor for cardiovascular pathology in HIV.
• Elevated inflammatory markers are associated with increased CVD risk in HIV-infected patients.

Conclusions:

• Early initiation of antiretroviral therapy (ART) is recommended.
• Aggressive management of traditional CVD risk factors is crucial for HIV-positive individuals.
• Further research into CVD mechanisms and chronic inflammation modification in HIV is needed.